Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126793291 | 12679329 | 1 | I | 20011205 | 20020522 | 20160824 | 20160824 | EXP | SN-BRISTOL-MYERS SQUIBB COMPANY-11884095 | BRISTOL MYERS SQUIBB | 34.00 | YR | F | Y | 0.00000 | 20160824 | OT | US | SN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126793291 | 12679329 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Oral | 600 MG, QD | Y | 20972 | 600 | MG | QD | ||||||
| 126793291 | 12679329 | 2 | SS | DIDANOSINE. | DIDANOSINE | 1 | Oral | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 126793291 | 12679329 | 3 | C | EPIVIR | LAMIVUDINE | 1 | Oral | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 126793291 | 12679329 | 4 | C | VIRAMUNE | NEVIRAPINE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 126793291 | 12679329 | 5 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | UNK | Y | 0 | |||||||||
| 126793291 | 12679329 | 6 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 126793291 | 12679329 | 7 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 126793291 | 12679329 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK | Y | 0 | |||||||||
| 126793291 | 12679329 | 9 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126793291 | 12679329 | 10 | C | NYSTATIN. | NYSTATIN | 1 | Unknown | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126793291 | 12679329 | 1 | HIV infection |
| 126793291 | 12679329 | 2 | HIV infection |
| 126793291 | 12679329 | 3 | HIV infection |
| 126793291 | 12679329 | 4 | HIV infection |
| 126793291 | 12679329 | 5 | Product used for unknown indication |
| 126793291 | 12679329 | 6 | Product used for unknown indication |
| 126793291 | 12679329 | 7 | Product used for unknown indication |
| 126793291 | 12679329 | 8 | Product used for unknown indication |
| 126793291 | 12679329 | 9 | Product used for unknown indication |
| 126793291 | 12679329 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126793291 | 12679329 | OT |
| 126793291 | 12679329 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126793291 | 12679329 | Pregnancy | |
| 126793291 | 12679329 | Tuberculosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126793291 | 12679329 | 1 | 20000118 | 20010507 | 0 | |
| 126793291 | 12679329 | 2 | 20000118 | 0 | ||
| 126793291 | 12679329 | 3 | 20000118 | 0 | ||
| 126793291 | 12679329 | 4 | 20010507 | 0 | ||
| 126793291 | 12679329 | 5 | 20010421 | 20010529 | 0 | |
| 126793291 | 12679329 | 6 | 20010419 | 20010429 | 0 | |
| 126793291 | 12679329 | 7 | 20010419 | 20010519 | 0 | |
| 126793291 | 12679329 | 8 | 20010419 | 20010519 | 0 | |
| 126793291 | 12679329 | 9 | 20010419 | 20010429 | 0 | |
| 126793291 | 12679329 | 10 | 20010419 | 20010429 | 0 |